{
    "Trade/Device Name(s)": [
        "CEDIA Opiate OFT Assay",
        "Thermo Scientific CEDIA Opiate OFT Assay"
    ],
    "Submitter Information": "Thermo Fisher Scientific, Clinical Diagnostic Division",
    "510(k) Number": "K101754",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981341"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "March 10, 2011",
    "Summary Letter Received Date": "March 14, 2011",
    "Submission Date": "January 6, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Opiates",
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Oral-Eze Saliva Collection System"
    ],
    "Instrument(s)/Platform(s)": [
        "MGC240"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "\u03b2-galactosidase-based enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay (EIA)",
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Scientific CEDIA Opiate OFT Assay for qualitative determination of opiates in oral fluid using enzyme immunoassay technology",
    "Indications for Use Summary": "Qualitative determination of opiates in human oral fluid at a cutoff concentration of 30 ng/mL, collected exclusively with Oral-Eze Saliva Collection System, for clinical laboratory use only; provides preliminary analytical results requiring confirmatory testing",
    "fda_folder": "Toxicology"
}